Cargando…

Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study

BACKGROUND: Many metabolic changes develop in patients with chronic kidney disease which often necessitate frequent biochemical analysis of blood. Saliva analysis as an alternative to blood has many advantages. The aims of this study were to evaluate levels of salivary creatinine and urea in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasisi, Taye Jemilat, Raji, Yemi Raheem, Salako, Babatunde Lawal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715295/
https://www.ncbi.nlm.nih.gov/pubmed/26775026
http://dx.doi.org/10.1186/s12882-016-0222-x
_version_ 1782410446184120320
author Lasisi, Taye Jemilat
Raji, Yemi Raheem
Salako, Babatunde Lawal
author_facet Lasisi, Taye Jemilat
Raji, Yemi Raheem
Salako, Babatunde Lawal
author_sort Lasisi, Taye Jemilat
collection PubMed
description BACKGROUND: Many metabolic changes develop in patients with chronic kidney disease which often necessitate frequent biochemical analysis of blood. Saliva analysis as an alternative to blood has many advantages. The aims of this study were to evaluate levels of salivary creatinine and urea in patients with chronic kidney disease in comparison to healthy individuals; to determine correlation between salivary creatinine/urea and blood creatinine/urea and to evaluate the diagnostic potential of saliva. METHODS: A case control study, involving 50 patients with late stage chronic kidney disease and 49 healthy individuals as control. Blood and saliva samples were analyzed for urea and creatinine levels. Data are presented as median with interquartile range and compared using Independent Samples Mann Whitney U test. Correlation between plasma and salivary creatinine as well as urea was determined using Spearman’s correlation test. Receiver operating characteristics (ROC) analysis was done to determine the diagnostic ability of salivary creatinine and urea and cut-off values were established. RESULTS: Median salivary creatinine levels were 2.60 mg/dl and 0.20 mg/dl while median salivary urea levels were 92.00 mg/dl and 20.50 mg/dl in patients with chronic kidney disease and controls respectively. Salivary levels of creatinine and urea were significantly elevated in chronic kidney disease patients (p < 0.001). In addition, there was positive correlation between blood and salivary creatinine as well as urea levels. Total areas under the curve for salivary creatinine and urea were 0.97 and 0.89 respectively. Cut-off values for salivary creatinine and urea were 0.55 mg/dl and 27.50 mg/dl respectively which gave sensitivity and specificity of 94 % and 85 % for creatinine; as well as 86 % and 93 % for urea. CONCLUSIONS: Findings of this study suggest that analysis of salivary creatinine and urea in patients with chronic kidney disease reflects their levels in blood. Hence, salivary creatinine and urea could be used as diagnostic biomarkers of chronic kidney disease.
format Online
Article
Text
id pubmed-4715295
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47152952016-01-17 Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study Lasisi, Taye Jemilat Raji, Yemi Raheem Salako, Babatunde Lawal BMC Nephrol Research Article BACKGROUND: Many metabolic changes develop in patients with chronic kidney disease which often necessitate frequent biochemical analysis of blood. Saliva analysis as an alternative to blood has many advantages. The aims of this study were to evaluate levels of salivary creatinine and urea in patients with chronic kidney disease in comparison to healthy individuals; to determine correlation between salivary creatinine/urea and blood creatinine/urea and to evaluate the diagnostic potential of saliva. METHODS: A case control study, involving 50 patients with late stage chronic kidney disease and 49 healthy individuals as control. Blood and saliva samples were analyzed for urea and creatinine levels. Data are presented as median with interquartile range and compared using Independent Samples Mann Whitney U test. Correlation between plasma and salivary creatinine as well as urea was determined using Spearman’s correlation test. Receiver operating characteristics (ROC) analysis was done to determine the diagnostic ability of salivary creatinine and urea and cut-off values were established. RESULTS: Median salivary creatinine levels were 2.60 mg/dl and 0.20 mg/dl while median salivary urea levels were 92.00 mg/dl and 20.50 mg/dl in patients with chronic kidney disease and controls respectively. Salivary levels of creatinine and urea were significantly elevated in chronic kidney disease patients (p < 0.001). In addition, there was positive correlation between blood and salivary creatinine as well as urea levels. Total areas under the curve for salivary creatinine and urea were 0.97 and 0.89 respectively. Cut-off values for salivary creatinine and urea were 0.55 mg/dl and 27.50 mg/dl respectively which gave sensitivity and specificity of 94 % and 85 % for creatinine; as well as 86 % and 93 % for urea. CONCLUSIONS: Findings of this study suggest that analysis of salivary creatinine and urea in patients with chronic kidney disease reflects their levels in blood. Hence, salivary creatinine and urea could be used as diagnostic biomarkers of chronic kidney disease. BioMed Central 2016-01-16 /pmc/articles/PMC4715295/ /pubmed/26775026 http://dx.doi.org/10.1186/s12882-016-0222-x Text en © Lasisi et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lasisi, Taye Jemilat
Raji, Yemi Raheem
Salako, Babatunde Lawal
Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
title Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
title_full Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
title_fullStr Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
title_full_unstemmed Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
title_short Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
title_sort salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715295/
https://www.ncbi.nlm.nih.gov/pubmed/26775026
http://dx.doi.org/10.1186/s12882-016-0222-x
work_keys_str_mv AT lasisitayejemilat salivarycreatinineandureaanalysisinpatientswithchronickidneydiseaseacasecontrolstudy
AT rajiyemiraheem salivarycreatinineandureaanalysisinpatientswithchronickidneydiseaseacasecontrolstudy
AT salakobabatundelawal salivarycreatinineandureaanalysisinpatientswithchronickidneydiseaseacasecontrolstudy